SI9890: AT-406

An oral, Smac mimetic that also serves as an inhibitor of apoptosis proteins: XIAP, cIAP1, and cIAP2. AT-406 has been shown to inhibit the survival of cancer cells and is currently in phase 1 clinical trials for human cancer treatment.

Info

Purity	>99.0% (HPLC), NMR(conforms)
Quantity	5mg
Molecular Weight	561.71 Da
Physical State	Lyophilized solid
Solubility	DMSO (112mg/ml); Ethanol (<112mg/ml);Water (<1mg/ml)
CAS No.	1071992-99-8
Storage	4°C, (-20°C Long term). The product can be shipped at room temperature.